LifeStance Health Group, Inc.
LFST
Positions held
Your positionsLFST isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- LifeStance Health Group operates in the growing mental health sector, which is increasingly recognized for its importance in overall healthcare, positioning the company well for future demand.
- In Q2 2026, LifeStance reported a revenue increase of 8% compared to the previous quarter, reaching $435 million.
- The company's gross margin improved to 35.2% in Q2 2026, up from 33.7% in Q1 2026.
- Despite growth, LifeStance has faced significant operating losses, indicating challenges in achieving profitability.
- In 2023, the company reported a net income loss of $186.262 million, reflecting ongoing financial struggles.
- The operating margin for the year 2023 was -17.9%, highlighting the need for operational improvements.
Fundamentals
| Market cap | $4.58B | Enterprise value | $4.86B | Trailing P/E | 92.77 | Forward P/E | 28.00 |
| PEG | — | Price / book | 3.12 | Beta | 1.24 | Dividend yield | 0.00% |
| Revenue growth | 26.1% | Earnings growth | — | Gross margin | 33.6% | Operating margin | 7.2% |
| Profit margin | 3.2% | ROE | 3.4% | ROA | 2.3% | Debt / equity | 0.32 |
| Current ratio | 1.38 | Free cash flow | $172.36M | Analyst recommendation | buy | Mean target | $14.40 |
| 52w high | $13.56 | 52w low | $4.77 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $435M | $403M | $382M | $364M | $345M | — |
| Op margin | 7.0% | 5.5% | 4.7% | 2.0% | -0.9% | — |
| Net income | $23.6M | $14.2M | $11.7M | $1.1M | -$3.8M | — |
| Gross margin | 35.2% | 33.7% | 33.0% | 32.0% | 31.4% | — |
| Gross profit | $153M | $136M | $126M | $117M | $108M | — |
| Operating income | $30.7M | $22.3M | $18.1M | $7.4M | -$3.0M | — |
- Revenue +8% vs prior quarter ($435M vs $403M).
- Gross margin 35.2% (was 33.7% prior quarter).
- Operating margin expanded to 7%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $1.4B | $1.3B | $1.1B | $860M | — |
| Op margin | 1.7% | -2.5% | -17.9% | -24.5% | — |
| Net income | $9.7M | -$57.4M | -$186M | -$216M | — |
| Gross margin | 32.4% | 32.2% | 28.6% | 27.6% | — |
| Gross profit | $461M | $402M | $302M | $237M | — |
| Operating income | $24.1M | -$31.6M | -$189M | -$210M | — |
Headlines — watch
• [WARN · balance sheet] Update: LifeStance Launches Secondary Offering, Concurrent Share Repurchase
News
2026-10-05 · 3 Stocks Under $50 We Keep Off Our Radar
2026-10-02 · 3 Healthcare Stocks That Concern Us
2026-09-28 · What’s Going On With LifeStance Health Group (LFST)?
2026-09-23 · LifeStance Health CTO Sells 42,067 Shares for $541,402
2026-09-21 · LifeStance Health Group (LFST): Buy, Sell, or Hold Post Q2 Earnings?
2026-09-18 · 3 Low-Volatility Stocks with Open Questions
2026-09-16 · LifeStance Health Group (NASDAQ:LFST): Strongest Q2 Results from the Outpatient & Specialty Care Group
2026-09-14 · Aveanna Healthcare Holdings Inc. (AVAH) Hits Fresh High: Is There Still Room to Run?
2026-09-11 · Zacks.com featured highlights include LifeStance Health, Tutor Perini, News, Everus Construction and HF Sinclair
2026-09-10 · These Two Healthcare Stocks Hit Key Milestones Today – Why Is Wall Street Bullish On Them?
2026-09-10 · Here's Why LifeStance Health Group (LFST) is a Great Momentum Stock to Buy
Price (daily)
Full chart · RSI · MACD · patterns